Last reviewed · How we verify
Postpartum depression
Approved treatments
- Zurzuvae · Biogen
Zurzuvae works by binding to the GABA A receptor, enhancing the inhibitory effects of GABA to calm overactive neurons. - ZULRESSO® · Supernus Pharmaceuticals, Inc.
- Zulresso · Sage Therap
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Postpartum depression patent landscape — cliff calendar, originator estates, attackable patents
- Postpartum depression treatment landscape brief
- Postpartum depression treatment updates RSS
Frequently asked questions about Postpartum depression
What drugs treat Postpartum depression?
Tracked treatments include Zurzuvae, ZULRESSO®, Zulresso.
What is the treatment for Postpartum depression?
Standard treatment for Postpartum depression includes Zurzuvae, ZULRESSO®, Zulresso. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Postpartum depression patent cliff · Postpartum depression CI report
- Treatment: Zurzuvae · Biogen
- Treatment: ZULRESSO® · Supernus Pharmaceuticals, Inc.
- Treatment: Zulresso · Sage Therap
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing